Product Images Atorvastatin Calcium
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 5 images provide visual information about the product associated with Atorvastatin Calcium NDC 68071-2342 by Nucare Pharmaceuticals,inc., such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
PDP - 68071 2342 3
This is a product label for NuCare Pharmaceuticals' Atorvastatin Calcium 40mg tablets, with lot number 000000 and National Drug Code 68071-2342-03. Each film-coated tablet contains Atorvastatin Calcium equivalent to 40mg Atorvastatin. The round white tablet is debossed with "40" on one side. The product should be stored at a controlled temperature of 68-77°F and kept out of reach of children. The label includes a warning to call a doctor for medical advice about side effects and the contact information for the FDA.*
Chemical Structure - atorvastatin calcium tablets 1
Figure 1 - atorvastatin calcium tablets 2
The text shows a graph of cumulative incidence over a period of 35 years. Additionally, it includes the hazard ratio (0.64) with its confidence interval (0.50-0.83) and p-value (0.0005). However, there is not enough information to know what is being measured or compared.*
Figure 2 - atorvastatin calcium tablets 3
The text describes a statistical analysis with a graph showing the cumulative hazard over time for an endpoint. The hazard decreases over time with HR of 0.63 and significant p-value. The x-axis represents time in years, up to 5 years, and the y-axis shows the percentage of cumulative hazard.*
Figure 3 - atorvastatin calcium tablets 4
This is a summary of subjects and their corresponding percentages experiencing cardiovascular events during a study involving Atorvastatin at two different doses, 10mg and 80mg. The study found a significant improvement in cardiovascular outcomes (HR 0.78, P=0.0002) for patients taking Atorvastatin 80mg as compared to Atorvastatin 10mg. The chart displays the time to the first major cardiovascular endpoint over a four year period.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.